CONFERENCE REPORT
XV International World AIDS Conference, 11-16 July 2004, Bangkok.
BANGKOK: ACCESS TO TREATMENTS
- Dollars, commerce, politics and prejudice all present obstacles to scaling up access to treatment in resource poor countries
- MTCT programmes in South Africa: nevirapine and the minister
BANGKOK: IVDU ISSUES
- Urgency of global access to ARV treatment for IV drug users
- Replace myths with evidence–based policies on IV drug use
BANGKOK: PREGNANCY AND MTCT
- Adding Combivir to single dose nevirapine for reduction of MTCT significantly reduces resistance
- Lopinavir/r levels reduced during pregnancy
BANGKOK: ANTIRETROVIRALS
- Another chance for 3TC in patients with M184V mutation?
- Kaletra monotherapy: small studies and early data
- Lowering dose of d4T can maintain efficacy and reduce side effects
BANGKOK: SIDE EFFECTS
BANGKOK: PK AND DRUG INTERACTIONS
- Fluconazole increases nevirapine levels and risk of serious hepatotoxicity
- Efavirenz interaction with rifampin may not require dose adjustment in patients with low body weight
- Tipranavir significantly lowers doses of saquinavir, amprenavir and lopinavir/r
BANGKOK: COINFECTION
- Responses to hepatitis vaccinations: an optimum window for protection?
- HBV vaccine, CD4 count and increasing response with double-dose
- Response to Hepatitis A (HAV) vaccine determined by CD4 count
BANGKOK: PAEDIATRICS
- Inventive ways to explain HAART and adherence to children
- Isoniazid has early and unexpected benefit in reducing childhood mortality
BANGKOK: TRANSMISSION
TREATMENT ACCESS
ANTIRETROVIRALS
- US FDA approves Glaxo and Gilead drug combinations
- Abbott applies for once-daily license for lopinavir/r
- AIDS activists respond to NIH decision on overriding HIV drug patent
PERIPHERAL NEUROPATHY
HEPATITIS COINFECTION
OTHER NEWS
CORRESPONDENCE
ON THE WEB
MEETINGS AND COURSES
- IAPAC conference in London
- Three-day course on methodological and statistical issues in clinical HIV research
PUBLICATIONS AND SERVICES FROM i-BASE

